Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2
| dc.contributor.author | Stepanova, Olena | |
| dc.contributor.author | Kryuchkiov, Y. | |
| dc.date.accessioned | 2012-11-28T07:50:32Z | |
| dc.date.available | 2012-11-28T07:50:32Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Trimetazidine MR showed high efficiency in the treatment of patients with CDH and diabetes mellitus type 2. The research has shown that adding trimetazidine MR (dosage 70 mg/day) to the basic therapy is advisable for tolerance increase to the physical activity and improvement of the quality of life in patients with CDH and diabetes mellitus type 2. | uk_UK |
| dc.identifier.citation | Stepanova O. Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2 / O. Stepanova, Y. Kryuchkiov // 5th International Scientific Interdisciplinary Conference (ISIC) for medical students and young doctors, Kharkiv, April 25–26, 2012 : Abstract book. – Kharkiv, 2012. – P. 77–78. | uk_UK |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/1922 | |
| dc.language.iso | en | uk_UK |
| dc.publisher | KNMU | uk_UK |
| dc.subject | diabetes mellitus type 2 | uk_UK |
| dc.subject | trimetazidine MR | uk_UK |
| dc.title | Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2 | uk_UK |
| dc.type | Thesis | uk_UK |